Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robotic mirror therapy: a new hope for children with cerebral palsy?

NCT ID NCT07763691

Symptom relief Sponsor: Medipol University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 18, 2026 · Updated 3 times

Summary

This trial tests whether adding a robotic glove to mirror therapy can improve arm and hand function in children with hemiparetic cerebral palsy. Participants will receive either robot-assisted or conventional mirror therapy alongside standard neurodevelopmental treatment for six weeks. Researchers will measure changes in spasticity, grip strength, hand skills, and daily living participation to see if the robotic approach offers extra benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Robot-assisted mirror therapy using a pneumatic robotic glove
What this could lead to
If effective, this approach could offer a more engaging and precise way to improve arm and hand function in children with cerebral palsy, potentially enhancing daily independence.
What could go wrong
This is a small early-stage trial with only 20 participants, so results may not apply broadly. The robotic glove may not outperform conventional therapy, and benefits could be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* Inclusion Criteria * Children classified within levels I, II, or III of the Gross Motor Function Classification System (GMFCS) * Children classified within levels I, II, or III of the Manual Ability Classification System (MACS). * Children classified within levels I, II, or III of the Communication Function Classification System (CFCS) * Medical records indicating a diagnosis of prenatal, intrapartum, or very early postnatal hemiparetic cerebral palsy, confirmed by neurologists and supported by magnetic resonance imaging (MRI). * Being between 6-17 years of age * Being able to cooperate * Attending age-appropriate classes * Ability to extend the wrist by more than 20 degrees and the metacarpophalangeal joints by more than 10 degrees * Ability to voluntarily release objects with the affected hand * Exclusion Criteria : * Diagnosis of intellectual disability and/or low cognitive level suitable for attending a special education school, * Behavioral and adaptation difficulties observed in the child during the administration of study assessments. * Diagnosis of attention deficit and/or hyperactivity disorder * History of epileptic seizures * Upper extremity fracture, muscle-tendon or bone surgery within the past six months, or use of any pharmacological agents to inhibit spasticity, including botulinum toxin administration * Uncorrected hearing and/or visual impairment * Severe muscle tone in the shoulder, elbow, or wrist, indicated by a Modified Ashworth Scale score greater than 3. * Any new treatment planned during the study period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy (CP) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy cerebral palsy spastic hemiplegic hemiplegia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebral palsy (CP) Hemiparetic cerebral palsy

Contacts and locations

Locations

  • Dilbade Özel Eğitim ve Rehabilitasyon Merkezi

    Istanbul, 34050, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.